2-丙烯酸,3-(1,1,3,3-四甲基甲硅醚基)丙基酯 | 140404-94-0

• 分子结构分类: 有机化合物
• 中文名称: 2-丙烯酸,3-(1,1,3,3-四甲基甲硅醚基)丙基酯
• 英文名称: <3-(2-propenoyloxy)propyl>tetramethyldisiloxane
• 英文别名: 2-Propenoic acid-3-(1,1,3,3-tetramethyldisiloxanyl)propyl ester；3-[dimethylsilyloxy(dimethyl)silyl]propyl prop-2-enoate
• CAS: 140404-94-0
• 化学式: C₁₀H₂₂O₃Si₂
• 分子量: 246.454
• InChiKey: AHXLWHHAGICSQS-UHFFFAOYSA-N

物化性质

• 沸点：
  243.5±23.0 °C(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.31
• 重原子数：
  15
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-[氯(二甲基)甲硅烷基]丙基丙-2-烯酸酯 在 盐酸 、 cellular KU-23 sulfocation-exchange resin 作用下， 以 甲苯 为溶剂， 反应 0.5h， 生成 2-丙烯酸,3-(1,1,3,3-四甲基甲硅醚基)丙基酯
  参考文献：
  名称：

  Efimov, Yu. T.; Tandura, T. A.; Kopylov, V. M., Journal of general chemistry of the USSR, 1991, vol. 61, # 10, p. 2083 - 2091

  摘要：

  DOI：

文献信息

• AMPHIPHILIC GRAFTS AND CO-NETWORKS AND PROCESS FOR MAKING SAME
  申请人：Kennedy Joseph P.

  公开号：US20100048818A1

  公开（公告）日：2010-02-25

  The present invention generally relates to amphiphilic grafts and co-networks made from at least one hydrophilic polymer and at least one hydrophobic polymer, and to processes for preparing such amphiphilic grafts and co-networks. In another embodiment, the present invention relates to amphiphilic co-networks formed from the combination of at least one polysiloxane and at least one polyacrylamide. In yet another embodiment, the present invention relates to amphiphilic co-networks formed from the combination of at least one polysiloxane, at least one polyacrylamide and at least one crosslinking agent.

  本发明通常涉及由至少一种亲水性聚合物和至少一种疏水性聚合物制成的两性接枝和共网络，以及制备这种两性接枝和共网络的方法。在另一种实施方式中，本发明涉及由至少一种聚硅氧烷和至少一种聚丙烯酰胺组合形成的两性共网络。在另一种实施方式中，本发明涉及由至少一种聚硅氧烷、至少一种聚丙烯酰胺和至少一种交联剂组合形成的两性共网络。
• BIO-ARTIFICIAL PANCREAS AND A PROCEDURE FOR PREPARATION OF SAME
  申请人：Kennedy Joseph P.

  公开号：US20100150984A1

  公开（公告）日：2010-06-17

  The present invention generally relates to implantable devices for producing insulin in diabetic animals and to methods of making same. Some embodiments include amphiphilic biomembranes for use in biological applications (e.g., as an alternative and/or supplemental insulin source). Some embodiments also include live insulin-producing cells contained within one or more amphiphilic membranes so as to prevent or diminish an immuno-response and/or rejection by the host.

  本发明通常涉及用于在糖尿病动物中产生胰岛素的可植入设备以及制造方法。一些实施例包括用于生物应用的两亲性生物膜（例如，作为替代和/或补充胰岛素来源）。一些实施例还包括包含在一个或多个两亲性膜内的活性胰岛素产生细胞，以防止或减轻宿主的免疫反应和/或排斥反应。
• Amphiphilic grafts and co-networks and process for making same
  申请人：The University of Akron

  公开号：US08247515B2

  公开（公告）日：2012-08-21

  The present invention generally relates to amphiphilic grafts and co-networks made from at least one hydrophilic polymer and at least one hydrophobic polymer, and to processes for preparing such amphiphilic grafts and co-networks. In another embodiment, the present invention relates to amphiphilic co-networks formed from the combination of at least one polysiloxane and at least one polyacrylamide. In yet another embodiment, the present invention relates to amphiphilic co-networks formed from the combination of at least one polysiloxane, at least one polyacrylamide and at least one crosslinking agent.

  本发明通常涉及由至少一种亲水性聚合物和至少一种疏水性聚合物制成的两亲嫁接物和共聚网络，以及制备这样的两亲嫁接物和共聚网络的方法。在另一种实施方式中，本发明涉及由至少一种聚硅氧烷和至少一种聚丙烯酰胺组合形成的两亲共聚网络。在另一种实施方式中，本发明涉及由至少一种聚硅氧烷、至少一种聚丙烯酰胺和至少一种交联剂组合形成的两亲共聚网络。
• Bio-artificial pancreas and a procedure for preparation of same
  申请人：Kennedy Joseph P.

  公开号：US08702810B2

  公开（公告）日：2014-04-22

  The present invention generally relates to implantable devices for producing insulin in diabetic animals and to methods of making same. Some embodiments include amphiphilic biomembranes for use in biological applications (e.g., as an alternative and/or supplemental insulin source). Some embodiments also include live insulin-producing cells contained within one or more amphiphilic membranes so as to prevent or diminish an immuno-response and/or rejection by the host.

  本发明通常涉及用于在糖尿病动物中产生胰岛素的可植入设备以及制造这些设备的方法。一些实施例包括用于生物应用的两亲性生物膜（例如，作为替代和/或补充胰岛素源）。一些实施例还包括包含于一个或多个两亲性膜中的活性胰岛素产生细胞，以防止或减少宿主的免疫反应和/或排斥。